Nuveen Asset Management’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | $13.4M | Buy |
149,116
+39
| +0% | +$3.51K | ﹤0.01% | 1433 |
|
2024
Q3 | $14.7M | Buy |
149,077
+1,182
| +0.8% | +$117K | ﹤0.01% | 1380 |
|
2024
Q2 | $13.7M | Sell |
147,895
-58,005
| -28% | -$5.38M | ﹤0.01% | 1375 |
|
2024
Q1 | $19.5M | Sell |
205,900
-269
| -0.1% | -$25.5K | 0.01% | 1198 |
|
2023
Q4 | $18.4M | Buy |
206,169
+18,630
| +10% | +$1.66M | 0.01% | 1214 |
|
2023
Q3 | $13.7M | Buy |
187,539
+62
| +0% | +$4.53K | ﹤0.01% | 1286 |
|
2023
Q2 | $15.6M | Sell |
187,477
-132
| -0.1% | -$11K | 0.01% | 1240 |
|
2023
Q1 | $14.3M | Buy |
187,609
+34,817
| +23% | +$2.65M | 0.01% | 1256 |
|
2022
Q4 | $12.7M | Buy |
152,792
+99,163
| +185% | +$8.23M | ﹤0.01% | 1338 |
|
2022
Q3 | $4.25M | Buy |
+53,629
| New | +$4.25M | ﹤0.01% | 1995 |
|
2020
Q4 | – | Sell |
-39,006
| Closed | -$4.35M | – | 3302 |
|
2020
Q3 | $4.35M | Sell |
39,006
-8,903
| -19% | -$992K | ﹤0.01% | 1987 |
|
2020
Q2 | $5.36M | Sell |
47,909
-20,487
| -30% | -$2.29M | ﹤0.01% | 1856 |
|
2020
Q1 | $5.3M | Buy |
68,396
+39,253
| +135% | +$3.04M | ﹤0.01% | 1687 |
|
2019
Q4 | $2.77M | Sell |
29,143
-15,884
| -35% | -$1.51M | ﹤0.01% | 2287 |
|
2019
Q3 | $3.43M | Sell |
45,027
-29,284
| -39% | -$2.23M | ﹤0.01% | 2147 |
|
2019
Q2 | $6.52M | Buy |
74,311
+25,697
| +53% | +$2.25M | ﹤0.01% | 1845 |
|
2019
Q1 | $4.4M | Buy |
48,614
+21,470
| +79% | +$1.94M | 0.02% | 528 |
|
2018
Q4 | $1.95M | Sell |
27,144
-123,215
| -82% | -$8.84M | 0.01% | 622 |
|
2018
Q3 | $14.4M | Buy |
150,359
+2,674
| +2% | +$256K | 0.08% | 372 |
|
2018
Q2 | $14.1M | Sell |
147,685
-599
| -0.4% | -$57K | 0.09% | 328 |
|
2018
Q1 | $13M | Buy |
148,284
+18,069
| +14% | +$1.59M | 0.08% | 331 |
|
2017
Q4 | $11.1M | Sell |
130,215
-5,343
| -4% | -$453K | 0.07% | 370 |
|
2017
Q3 | $11.7M | Buy |
135,558
+13,961
| +11% | +$1.21M | 0.08% | 361 |
|
2017
Q2 | $9.39M | Buy |
+121,597
| New | +$9.39M | 0.06% | 422 |
|